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OBJECTIVES The purpose of this study was to describe the health status (symptoms, function, and quality
of life) changes of elderly patients undergoing coronary artery bypass grafting (CABG) and
compare these to younger patients.
BACKGROUND Despite increasing use of CABG in the elderly, few data exist about elderly patients’ health
status benefits from CABG.
METHODS A total of 690 consecutive patients (n  156, 75 years of age; n  534, 75 years of age)
from a single center were administered the Seattle Angina Questionnaire (SAQ) at baseline
and at one year. The first 224 patients were also given monthly questionnaires for six months
after CABG.
RESULTS Although peri-operative mortality was similar (2.6% vs. 2.2%, p  NS), one-year mortality
was greater in older patients (11.5% vs. 5.4%, p  0.008). Among survivors, similar health
status benefits were observed one year after surgery (SAQ change scores for Physical Function
21.5  27.0 vs. 19.7  27.0, p  0.67; Angina Frequency 30.1  25.7 vs. 24.6  25.6, p 
0.07; and Quality of Life 37.7  21.8 vs. 33.6  25.2, p  0.16). In 224 patients assessed
monthly, elderly patients’ physical function scores were significantly lower than the younger
group until one year. The age-time interaction term was significant (p  0.003), confirming
a slower recovery of physical function. In contrast, angina relief and quality of life
improvement did not differ by age.
CONCLUSIONS Despite a slower rate of physical recovery, older patients derived similar health status benefits
from CABG compared with younger patients. These data should assist physicians in
counseling elderly patients and suggest that age alone should not be a deterrent for
recommending bypass surgery. (J Am Coll Cardiol 2003;42:1421–6) © 2003 by the
American College of Cardiology Foundation
Cardiovascular disease is the major cause of death, disabil-
ity, and health care use among the elderly (1). The Pan
American Health Organization estimates that by the year
2010 the growth rate of the population60 years will be 3.5
times that of the total population (2). Furthermore, the
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Society of Geriatric Cardiology anticipates that by the year
2030 there will be 51 million people in the U.S. over the
age of 65, including 7 million over the age of 85. The
growth of the elderly population and the prevalence of
coronary disease among these individuals warrant careful
evaluation of potential treatment options. Selecting among
the potential choices of medical therapy, percutaneous
coronary intervention, and coronary artery bypass grafting
(CABG) requires careful evaluation of treatment risks and
benefits.
While peri-procedural risks are known to be higher in
elderly patients (3), including greater peri-procedural mor-
tality (4,5), few data regarding the benefits of coronary
revascularization in the elderly are available. This stems, in
part, from the systematic exclusion of older patients from
randomized clinical trials of therapy (6,7). In the absence of
clinical trials, however, information gleaned from observa-
tional registries may provide valuable evidence about the
treatment benefits of revascularization in the elderly (8,9).
Towards that end, we developed a procedural registry to
define the health status benefits of CABG with a focus on
the relief of symptoms, improvement in physical function-
ing, and augmentation of quality of life. The purpose of this
report is twofold: 1) to report the one-year health status
benefits of elderly patients (patients 75 years of age)
undergoing CABG compared with younger patients, and 2)
to provide descriptive data about the pace of health status
improvement over time in a subset of this cohort. It is hoped
that these data will be useful in counseling elderly patients
about their expected outcomes from CABG.
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METHODS
Patient population. The process of patient recruitment,
success, and possible selection biases have been previously
described (10). From February 1999 through August 2000,
patients undergoing CABG at the Mid America Heart
Institute, an urban tertiary care center, participated in an
observational research study documenting their post-
treatment health status recovery. During the collection
period, 907 patients underwent cardiac surgery for a bypass
procedure (valve surgeries with concomitant bypass were not
included). Nineteen (2%) of these emergent cases could not
be interviewed before their operation and died during their
procedure. In addition, 37 patients (4%) were missed and
not given the opportunity to participate. Finally, 18 (2%)
patients were non-English-speaking and 143 (16%) refused
to participate.
All consenting patients were administered a series of
questionnaires at baseline and at one year after their proce-
dure. In addition, patients enrolled in the first phase of the
study (n  224) were given monthly questionnaires for six
months after their procedure. Approval from the Saint
Luke’s Hospital Institutional Review Board was obtained
before the conduct of this study.
Health status. Health status assessments were performed
with the Seattle Angina Questionnaire (SAQ), a 19-item,
disease-specific measure for patients with coronary artery
disease. The SAQ quantifies five clinically relevant dimen-
sions of coronary artery disease: physical limitation, recent
change in anginal symptoms, angina frequency, treatment
satisfaction, and quality of life. Of these five scales, we chose
to focus upon the three most clinically relevant domains,
physical limitation, angina frequency, and quality of life.
The treatment satisfaction results are also described to
provide insights into the perception of older and younger
patients with respect to their satisfaction with care. The
scales used in these analyses range from 0 to 100, where
higher scores indicate better function, fewer symptoms, and
higher quality of life. The SAQ has well-established valid-
ity, reproducibility, and sensitivity to clinical change
(11,12). In addition, it has been shown to be predictive of
one-year mortality (13).
CLINICAL AND PROCEDURAL ASSESSMENTS OF DISEASE SE-
VERITY. The Mid America Heart Institute has maintained
a procedural database for patients undergoing coronary
interventions since 1982. This database provides a detailed
description of the coronary anatomy, the type of revascular-
ization performed, procedural results, and post-procedure
complications; it uses the American College of Cardiology
and Society of Thoracic Surgeons data definitions.
FOLLOW-UP. Patients were contacted one year after their
procedure to reassess their health status. Before contacting
patients, a query of the Social Security Administration
Death Master File was conducted, and local hospital records
were examined to minimize the likelihood of contacting the
family of someone who had expired. Patients were then
contacted by telephone for an interview that included a
report of interval events, cardiac procedures outside of the
Mid America Heart Institute, and their health status. A
minimum of eight and, in some cases, over 20 attempts were
made to contact each patient.
In addition to the one-year follow-up data collected for
all patients, the first 224 patients undergoing CABG were
resurveyed at monthly intervals throughout the first six
months of their recovery. The purpose of these assessments
was to document the recovery of health status after revas-
cularization. These patients, upon discharge from the hos-
pital, were given a set of six questionnaire packets and
instructed to complete one each month. Patients were
reminded by telephone before the due date of each packet to
complete and return the questionnaires. If they misplaced
their packets they were either sent new ones or had the
instruments administered by telephone.
Statistical analysis. Patients were divided into two age
groups: those 75 years of age and those 75 years of age
(6). For descriptive purposes, categorical data are reported as
frequencies, and differences between age groups were com-
pared with a chi-square or Fisher exact test when the
frequency in any given cell was 5. Continuous data are
reported as the mean  SD, and differences between age
groups were tested using an analysis of variance.
The primary analysis evaluated the one-year change in
health status scores for the SAQ Physical Limitation,
Angina Frequency, and Quality of Life domains. An anal-
ysis of variance was used to compare the change in scores
between the elderly and younger cohorts. To measure the
independent effect of age, a multivariate analysis of variance
was used to control for sociodemographic, clinical, and
health status characteristics that differed by age at baseline.
Those variables that differed significantly by age group on a
univariate basis (p  0.2) were included as covariates in the
final model and included gender, race, smoking, diabetes,
hypercholesterolemia, congestive heart failure (CHF), cere-
brovascular disease, left main coronary artery disease, num-
ber of diseased vessels, and permanent neurologic compli-
cations.
Patients enrolled in the first phase of the study had SAQ
data at monthly intervals for the first six months after
CABG. This analysis was conducted to evaluate the recov-
ery process and compare that rate of recovery between
elderly and non-elderly patients. Repeated measures analysis
of variance was performed using change in SAQ scores at 1,
2, 3, 4, 5, 6, and 12 months as dependent variables, with
Abbreviations and Acronyms
CABG  coronary artery bypass grafting surgery
CHF  congestive heart failure
SAQ  Seattle Angina Questionnaire
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age, time, and an age  time interaction term as indepen-
dent variables. To evaluate the independent influence of age
on health status recovery curves, a multivariate repeated
measures model was developed using the same independent
covariates described for the analysis of one-year change
scores. A compound symmetry covariance structure was
used (14). Significance for all statistical tests was established
as a p value of 0.05.
Handling of missing data. The vital status of all patients
was determined through query of the Social Security Master
Death File and inpatient and outpatient records. Health
status data may have been missing from one of three
possible causes: 1) patients died during follow-up (n  47;
6.8%); 2) patients were lost to follow-up (n  45; 6.5%); or
3) patients did not complete enough of the SAQ at either
baseline or follow-up to generate a change score (i.e.,
contacted by telephone but did not want to participate in
the follow-up survey, ran out of time and did not want to be
recontacted, and so forth [n  145; 20.5%]). Only data
from those who survived for 12 months of follow-up are
reported. This is consistent with our intention that clini-
cians interpreting these reported changes in health status
would predicate them on the patient surviving for at least
one year.
To explore potential selection biases introduced by in-
complete data, we compared each of the clinical character-
istics described in Table 1 among those patients with at least
one SAQ domain change score to those without any
available change scores. Patients without a change score
more frequently had CHF (22% vs. 9%), chronic obstructive
pulmonary disease (14% vs. 7%), and single-vessel disease
(15% vs. 5%) and less often had had three-vessel disease
(61% vs. 75%). Age was not associated with the presence of
incomplete data.
To further examine the impact of missing data, multiple
imputations using a Markov-chain Monte Carlo method
were generated (15). The complete data set (using imputed
SAQ scores) was then reanalyzed using the methods de-
scribed earlier. Multiple imputation analyses suggested no
systematic bias resulting from missing data. Accordingly,
only complete data are presented.
RESULTS
Of the 690 patients enrolled in the study, 156 (22.6%) were
over 75 and 534 were younger. Their baseline characteristics
are described in Table 1. Peri-procedural complications
were infrequent. Among the 16 (2.3%) peri-procedural
deaths, 12 were in the younger patients and 4 were in the
elderly (2.2% vs. 2.6%, p  NS). Table 2 demonstrates the
non-fatal peri-operative complications by age. Older pa-
tients were more likely to experience neurologic, operative,
and renal complications. They also were more likely to
require prolonged ventilatory support. Within 12 months,
there were an additional 31 deaths, of which 13 (8.6%) were
in the 75 age group and 18 (3.5%) were in the 75 group
(p  0.008).
Ultimately, 138 patients (mean age 79.8 3.5) over 75
years of age and 505 patients 75 years of age (mean age 
62.8  8.7) were eligible for health status follow-up. Table
1 shows the demographic, clinical, and disease severity
characteristics of the patients by age group. In brief, our
patient population tended to be male, with a larger propor-
tion of younger patients currently smoking, having diabetes
or three-vessel disease. A history of CHF and cerebrovas-
cular disease was nearly twice as prevalent among elderly
patients.
Baseline and changes from baseline in health status.
Table 3 presents the baseline, one-year, and unadjusted
change scores in SAQ physical limitation, angina frequency,
and quality of life scores for those 75 years of age and
those 75 years of age. At baseline, SAQ physical limita-
tion scores (67.4 23.9 vs. 70.8 25.0 in younger patients,
p  0.36), angina frequency scores (66.7  23.9 vs. 71.3 





(n  138) p Value
Demographics
Mean age 62.8  8.7 79.8  3.5
Male 375 (74.3%) 84 (61.3%) 0.003
White 474 (94.8%) 133 (98.0%) 0.138
Comorbidities
Currently smoking 94 (19.8%) 4 (3.0%) 0.0001
Diabetes 149 (30.0%) 22 (16.0%) 0.001
Hypertension 403 (79.8%) 110 (79.7%) 0.981
Hypercholesterolemia 342 (77.9%) 142 (71.4%) 0.073
History of CHF 55 (10.9%) 28 (20.3%) 0.004
Renal failure 17 (3.4%) 7 (5.1%) 0.349
Peripheral vascular disease 66 (13.1%) 22 (15.9%) 0.384
Cerebrovascular disease 46 (9.1%) 30 (21.7%) 0.0001
COPD 46 (9.1%) 14 (10.1%) 0.711
Disease severity
Intra-aortic balloon pump 20 (4.0%) 7 (5.1%) 0.562
Urgent status 85 (16.9%) 26 (18.8%) 0.587
Poor LV function 161 (38.4%) 45 (32.6%) 0.871
Left main disease 110 (24.9%) 36 (18.2%) 0.062
Three-vessel disease 330 (74.7%) 120 (60.9%) 0.0004
CHF  congestive heart failure; COPD  chronic obstructive pulmonary disease;
LV  left ventricle.





(n  138) p Value
Temporary (72 h) neurologic
deficit
5 (1.0%) 6 (4.4%) 0.007
Permanent (72 h) neurologic
deficit
4 (0.8%) 6 (4.4%) 0.003
Perioperative myocardial
infarction
1 (0.2%) 1 (0.7%) 0.326
Prolonged ventilator support 15 (3.0%) 8 (5.8%) 0.116
Postoperative renal dysfunction 22 (4.4%) 13 (9.4%) 0.020
Postoperative bleeding requiring
repeat surgery
9 (1.8%) 1 (0.7%) 0.372
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25, p 0.12), and quality of life scores (55.7 20.4 vs. 56.1
 23.6, p  0.88) were similar.
At one year, the SAQ angina frequency and physical
limitation scores of older and younger patients were similar,
but a slightly higher SAQ quality of life score was reported
among the elderly (SAQ quality of life score  93.4  12.6
vs. 89.7  14.6, p  0.03). Importantly, the change scores
of the SAQ, reflecting the health status benefits conferred
by CABG, were not significantly different. The mean
change in SAQ quality of life scores for those75 was 37.7
 21.8 points, compared with a mean improvement in the
younger cohort of 33.6  25.2 points (p  0.16). The SAQ
physical limitation change scores were 21.5 27.0 for those
75 and 19.7  27.0 for those 75 (p  0.67), and the
mean change in SAQ angina frequency scores was 30.1 
25.7 for those75 and 24.6 25.6 points for those75 (p
 0.07). Patients’ satisfaction with their treatment for
coronary disease was high at baseline and improved further
by one year. No differences between older and younger
patients were observed.
The recovery process. As demonstrated in the primary
analyses, both age groups experienced substantial improve-
ments in their health status scores by one year. Among the
subset of patients (n 224; 5675 years old and 168 75
years old) in whom we tracked serial monthly changes in
health status, interesting differences in the rates of recovery
for different domains of health were detected (Fig. 1).
After CABG, the physical limitation scores of both
cohorts decreased during the first post-procedure month,
but by the second postoperative month both older and
younger patients’ physical limitation scores began to im-
prove, a process that continued throughout follow-up.
Elderly patients’ mean physical limitation score however,
remained consistently lower than the younger group until
one year, suggesting a slower pace of physical recovery (Fig.
1a). The age-time interaction term of the repeated measures
model was statistically significant (p  0.009), confirming a
slower recovery of physical function.
In contrast to the slow recovery of physical function,
angina relief occurs rapidly and is sustained throughout
follow-up (Fig. 1b) in both groups. One month after
CABG, both the elderly and the younger patients have
improved their SAQ Angina Frequency scores (i.e., less
angina) dramatically and similarly (1-month change  22.3
 23.8 vs. 21.3  30.6; p  0.86 for the difference between
older and younger patients), and the rate of symptom
improvement over time did not differ (p  0.55).
Consistent with the improvement in symptoms, quality
of life improved significantly in both the older and younger
Table 3. SAQ Baseline and One-Year Scores
SAQ Domains Age <75 Age >75 p Value
Physical limitation
Baseline score 70.8  25.0 67.4  23.9 0.363
One-year score 90.5  19.0 88.9  20.0 0.569
Change score 19.7  27.0 21.5  27.0 0.665
Angina frequency
Baseline score 71.3  25.0 66.7  23.9 0.120
One-year score 95.9  13.3 96.8  10.9 0.530
Change score 24.6  25.6 30.1  25.7 0.069
Quality of life
Baseline score 56.1  23.6 55.7  20.4 0.876
One-year score 89.7  14.6 93.4  12.6 0.031
Change score 33.6  25.2 37.7  21.8 0.161
Treatment satisfaction
Baseline score 86.6  17.8 85.3  13.5 0.571
One-year score 92.1  16.5 89.8  17.7 0.425
Change score 5.5  19.0 4.5  18.2 0.648
SAQ  Seattle Angina Questionnaire.
Figure 1. Monthly health status recovery curves among the 224 patients
enrolled in the substudy focusing upon the recovery of health status after
coronary artery bypass grafting surgery. SAQ  Seattle Angina Question-
naire.
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cohorts (Fig. 1c), although at a pace intermediate between
symptom relief and physical function. Improvements in
SAQ quality of life scores occurred rapidly in both the older
(1-month change  17.4  23.9) and younger patients
(1-month change  11.1  30.0; p  0.81 for the
difference) and continued throughout the year of follow-up
(Fig. 1c). The rate of recovery was not significantly different
between the two age groups (p  0.44).
DISCUSSION
The elderly are currently the fastest growing segment of a
cardiologist’s practice (16) and data are needed to ade-
quately counsel patients so that their expectations are
aligned with their likely outcomes. This study reveals that
older patients have similar peri-procedural mortality but die
more frequently over the following year than younger
patients. In addition, they experienced a higher frequency of
peri-procedural complications than younger patients. Yet,
despite these transient complications, the health status
benefits one year after the procedure are at least as good in
the elderly as in younger patients. One year after CABG,
the elderly attain similar symptom relief, functional im-
provement, and quality of life augmentation from surgical
revascularization as younger patients. This is the first study
that we are aware of that describes elderly patients’ disease-
specific health status and recovery after CABG.
Interestingly, the recovery of physical function is slower
among the elderly when compared with younger patients.
We found that while all patients had a transient decrement
in function one month after CABG, the amount of deteri-
oration was greater in the elderly and the recovery was
slower than that of younger patients. At one year, however,
physical function was similar between groups. This insight
should inform clinicians that when counseling older patients
about CABG, a slow recovery of physical function—lasting
throughout an entire year—should be anticipated. In con-
trast, the relief of symptoms and improvement in quality of
life is rapid and not affected by age.
Given the similar health status benefits, the principal
barrier in recommending CABG to elderly patients is their
greater perceived risk. Yet, several studies have shown that
age alone is not sufficient to avoid recommending CABG
(17–20) and that the elderly may benefit in terms of their
functional status and quality of life (19,20). For example,
Keon demonstrated a steady reduction in mortality from
isolated CABG in the elderly over the past three decades
(21). While he attributed these results to improved surgical
techniques, better postoperative care, and more careful
selection of surgical candidates, his finding of only a slight
increase in mortality among older patients (3.7% vs. 1.6%)
argues that age alone is insufficient to avoid coronary surgery
(21). Our current study demonstrates no significant differ-
ence in peri-operative mortality, although other peri-
operative complications did occur more often in the elderly.
Furthermore, our finding of higher mortality one year after
surgery does not necessarily reflect poor outcomes from
surgery, because older patients are naturally expected to have
a higher mortality over time than younger patients. In fact,
among a cohort of stable outpatients with coronary disease,
age was the strongest predictor of one-year mortality (13).
Several limitations to the present study are noteworthy.
First, this prospective registry included only those patients
selected by their physician to undergo CABG. Without a
careful description of the patients considered but not se-
lected for CABG, we cannot describe what characteristics
the surgeons used in identifying suitable candidates. It is
possible that careful selection of patients at the Mid Amer-
ica Heart Institute may have identified those most likely to
derive health status benefits from CABG while alternative
treatments were used in those with less potential to benefit.
Replicating these findings at other institutions should dispel
this possibility. A second concern is our incomplete
follow-up (6.5% lost to follow-up and 20.5% incomplete
follow-up). Those who responded to follow-up differed slightly
from those that did not in that they had more heart failure,
lung disease, and less severe coronary disease. Yet, the similar-
ity of their SAQ scores at baseline, the absence of a difference
in follow-up rates by age, and the failure of multiple imputa-
tion techniques to suggest different results reassure us that
these findings are generalizable to our total population.
Finally, patients who died during follow-up were ex-
cluded from our analyses. This may cause a false elevation of
SAQ scores as those who died may have had worse health
status before their death. However, we feel that clinically,
the integration of death and health status is best done by
individually describing the outcomes of each and allowing
patients and their physicians to independently incorporate
both pieces of information to select a treatment most
aligned with patients’ individual goals and preferences.
Others have proposed imputing scores of 0 for those who
died, substituting the last value carried forward, or develop-
ing probabilities of “good function” at a future point in time
while substituting a 0 probability for those who die (22,23).
Although these approaches are valuable tools in clinical
trials, where the scientific question is which treatment
results in better outcomes, the purpose of this paper is to
provide a description of the relative benefits of CABG
among older compared with younger patients. Thus, we feel
that presenting the risks of death and the health status
benefits independently is the most appropriate strategy.
In conclusion, this observational study reveals important
information about the recovery of the elderly from CABG.
Age alone does not appear to exert an important influence
on the health status outcomes of CABG—often the prin-
cipal indication for the procedure. Rather, the potential for
surgery to improve patients’ symptoms, function, and qual-
ity of life along with a careful quantification of procedural
risk using appropriate risk models (3) should dominate the
decision process. It is important, however, to inform elderly
patients of the slower recovery of physical function that is
anticipated so that their expectations for the pace of
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recovery are appropriate. With such counseling, the choice
to pursue surgical revascularization may be better tailored to
the goals and preferences of individual patients.
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